Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing - Pharmaceutical Technology

When Eli Lilly's Lebanon campus is complete, it will manufacture several of the pharma's APIs and genetic medicines to serve US patients. When the campus is complete, it will produce several of Lilly’s APIs and genetic medicines to serve US patients. Eli Lilly is expanding its presence within its home state of Indiana with a $4.5bn pledge to its Lebanon campus. Credit: rarrarorro / Shutterstock.com. Eli Lilly has shared plans to invest a further $4.5bn into its manufacturing presence in Indiana, taking the pharma company’s total investment into the state to $21bn since 2020. Through this commitment, Lilly will expand…

Source: Pharmaceutical Technology